XML 56 R10.htm IDEA: XBRL DOCUMENT
v3.20.1

EARNINGS PER SHARE | 3 Months Ended
--- | ---
Mar. 31, 2020
Earnings Per Share, Basic and Diluted [Abstract] |
EARNINGS (LOSS) PER SHARE | EARNINGS PER SHARE The computation of basic and diluted earnings per common share was as follows (in millions, except per share data):
| Three Months Ended March 31,
| 2020 |  | 2019
Amounts attributable to Quest Diagnostics’ common stockholders: |  |  |  |  |
Net income attributable to Quest Diagnostics | $ | 99 |  |  | $ | 164 |
Less: Earnings allocated to participating securities | — |  |  | 1 |
Earnings available to Quest Diagnostics’ common stockholders – basic and diluted | $ | 99 |  |  | $ | 163 |
Weighted average common shares outstanding – basic | 134 |  |  | 134 |
Effect of dilutive securities: |  |  |  |  |
Stock options and performance share units | 1 |  |  | 2 |
Weighted average common shares outstanding – diluted | 135 |  |  | 136 |
Earnings per share attributable to Quest Diagnostics’ common stockholders: |  |  |  |  |
Basic | $ | 0.74 |  |  | $ | 1.22 |
Diluted | $ | 0.73 |  |  | $ | 1.20 |
The following securities were not included in the calculation of diluted earnings per share due to their antidilutive effect:
| Three Months Ended March 31,
| 2020 |  | 2019
Stock options | 2 |  |  | 4 |

X
- References No definition available. + Details
Name: | us-gaap_EarningsPerShareBasicAndDilutedAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for earnings per share. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 260 -URI http://asc.fasb.org/topic&trid=2144383 + Details
Name: | us-gaap_EarningsPerShareTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration